Apexigen, Inc. Proceeds from Issuance Initial Public Offering
Apexigen, Inc. reported Proceeds from Issuance Initial Public Offering of $0 for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2022-08-18
- Apexigen, Inc. proceeds from issuance initial public offering for the quarter ending 2022-06-30 was $0.00.
- Apexigen, Inc. proceeds from issuance initial public offering for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Apexigen, Inc. proceeds from issuance initial public offering for the quarter ending 2021-12-31 was $0.00.
- Apexigen, Inc. proceeds from issuance initial public offering for the quarter ending 2021-09-30 was $0.00.
- Apexigen, Inc. proceeds from issuance initial public offering for fiscal 2021 was $57.50M.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 4 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|---|
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-18 | $0.00 10-Q · filed 2022-08-18 | $0.00 derived: sum of 3 quarters · filed 2022-08-18 | $0.00 derived: sum of 4 quarters · filed 2022-08-18 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-23 | $0.00 derived: sum of 2 quarters · filed 2022-05-23 | $0.00 derived: sum of 3 quarters · filed 2022-05-23 | $0.00 derived: sum of 4 quarters · filed 2022-08-18 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-07 | $0.00 derived: sum of 2 quarters · filed 2022-04-07 | $0.00 derived: sum of 3 quarters · filed 2022-08-18 | $57.50M 10-K · filed 2022-04-07 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-12-09 | $0.00 derived: sum of 2 quarters · filed 2022-08-18 | $57.50M 10-Q · filed 2021-12-09 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-18 | $57.50M 10-Q · filed 2022-08-18 | |||
| 2021-03-31 | $57.50M 10-Q · filed 2022-05-23 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2021-12-09 |